Reconstruction of a Large Lumbar Carcinoma Defect Using a Subtype III Keystone Flap: Case Report

Authors

DOI:

https://doi.org/10.5195/ijms.2025.3909

Keywords:

Carcinoma, Plastic Surgery, Surgical Flaps, Reconstructive Surgery, Case Report

Abstract

Background. Systemic inflammation is theorized to alter lipid metabolism through cytokine-driven suppression of hepatic synthesis, changes in lipoprotein clearance, and impaired reverse cholesterol transport. These theoretical changes include reductions in low-density lipoprotein (LDL), high-density lipoprotein (HDL), and total cholesterol (TC) with elevations in triglycerides (TG). While these mechanisms are biologically plausible and supported in experimental settings, large-scale inpatient data confirming these patterns remain limited. Clarifying how lipid profiles shift during acute inflammation is essential for accurate cardiovascular risk assessment and interpretation of lipid panels during illness.

 

Methods. We conducted a retrospective analysis of electronic medical record data from a tertiary academic medical center between 2020 and 2024. A total of 5,060 hospitalized adult patients with C-reactive protein (CRP) >5 mg/L and at least one lipid panel were included. Patients were stratified into CRP categories: 5–20, 20–50, 50–100, and >100 mg/L. Mean values for TG, LDL, HDL, and TC were compared across groups using one-way ANOVA. Tukey HSD post-hoc testing was performed to evaluate between-group differences.

 

Results. Among the 5,060 patients included, th mean age was 50.5 years, and 53.4% were female. As CRP increased, LDL declined from 105.53 mg/dL in the 5-20 mg/L group to 87.94 mg/dL in the >100 mg/L group, and TC declined from 187.04 to 157.28 mg/dL. HDL also showed a consistent inverse relationship with CRP, decreasing from 48.89 to 38.68 mg/dL across categories. ANOVA revealed significant group differences for LDL (F = 68.53, p < 0.0001), HDL (F = 94.83, p < 0.0001), TC (F = 99.39, p < 0.0001), and TG (F = 5.39, p = 0.0011). Tukey post-hoc tests showed significant LDL reductions between the 5-20 and >100 mg/L groups (mean difference = –17.60 mg/dL, p < 0.0001) and the 20-50 and >100 mg/L groups (mean difference = –9.72 mg/dL, p < 0.0001). For TC, the 5-20 and >100 mg/L comparison showed a statistically significant reduction (mean difference = –29.77 mg/dL, p < 0.0001). For HDL, significant reductions were observed between the 5-20 and >100 mg/L groups (mean difference = –10.21 mg/dL, p < 0.0001), 20-50 and >100 (mean difference = –7.58 mg/dL, p < 0.0001), and 50-100 and >100 (mean difference = –3.09 mg/dL, p = 0.0023).

 

Conclusion. This study demonstrates a clear inverse association between CRP levels and lipid values, particularly LDL, HDL, and TC, in hospitalized patients. These patterns reflect inflammation-induced suppression of lipoprotein synthesis and metabolic remodeling. Lipid profiles obtained during inflammatory states may underestimate baseline atherosclerotic cardiovascular risk, highlighting the importance of contextual interpretation to avoid delayed or missed preventive interventions.

 

Figure 1. Mean Lipid Levels by CRP Category in Hospitalized Patients (N = 5,060)

 

CRP Category (mg/L)

Triglycerides (mg/dL)

LDL (mg/dL)

HDL (mg/dL)

Total Cholesterol (mg/dL)

5–20

174.31

105.53

48.89

187.04

20–50

163.55

97.66

46.26

174.11

50–100

169.16

89.57

41.78

160.45

>100

186.74

87.94

38.68

157.28

ANOVA F-value

5.39

68.53

94.83

99.39

ANOVA P-value

0.0011

<0.0001

<0.0001

<0.0001

 

Downloads

Published

2025-12-31

How to Cite

Peñafiel-Pallares, W. S., Brito-Balanzategui, C., Velez-Posada, J., & Velasco, J. (2025). Reconstruction of a Large Lumbar Carcinoma Defect Using a Subtype III Keystone Flap: Case Report. International Journal of Medical Students, 13, S221. https://doi.org/10.5195/ijms.2025.3909

Issue

Vol 13. (2025): Supplement 1

Section

Abstracts of the WCMSR

License

Copyright (c) 2025 Wilson Sebastian Peñafiel-Pallares, Camila Brito-Balanzategui, Juan Velez-Posada, Jonathan Velasco

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org